When vaccines were developed, LMICs often paid higher prices and still found themselves at the back of the distribution line. Despite ... as outbreaks intensified in Central and East Africa ...

Novartis is paying $925 million upfront to acquire Anthos Therapeutics, whose launch the pharma backed in February 2019.

Operator Good day, ladies and gentlemen, and welcome to the Exelixis fourth quarter and fiscal year 2024 financial results ...

Q4 2024 Earnings Call Transcript February 11, 2025 Exelixis, Inc. misses on earnings expectations. Reported EPS is $0.48 EPS, ...

Exelixis, Inc. (Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal study of patients with extra-pancreatic ...

Q2 2025 Earnings Call Transcript February 5, 2025 Accuray Incorporated beats earnings expectations. Reported EPS is $0.02, expectations were $-0.01. Operator: Good day, and welcome to the Accuray ...

Q4 2024 Earnings Call Transcript February 4, 2025 Amgen Inc. beats earnings expectations. Reported EPS is $5.31, expectations were $5.04. Operator: My name is Julienne, and I will be your conference ...

Tom Lee: This is Tom Lee, Editor-in-Chief of NEJM Catalyst. We’re talking today with my longtime ... who once said to me as a throwaway line, “I don’t want to be a leader; I just want to make my ...

What would you risk to get your business off the ground? Kim Vaccarella lost her kids’ college fund but says it was worth it to follow her dreams — including sending her kids to college.

Presentation Unidentified Speaker Thank you. Thank you, Julianne. Good afternoon, everyone, and welcome to our 4th-quarter ...

14,53 An international HLH registry recently reported an astonishing pre-HSCT survival rate of 91% among 57 symptomatic patients with verified primary HLH who received first-line treatment with ...

A data sharing statement provided by the authors is available with the full text of this article at NEJM.org. Supported by F. Hoffmann–La Roche. Disclosure forms provided by the authors are ...